| Adipose Tissue and Metabolism | Lifetime | 43 | DE 4 | 99.82 |
| Diet and metabolism studies | Lifetime | 57 | DE 2 | 99.82 |
| Diet, Metabolism, and Disease | Lifetime | 32 | DE 1 | 99.71 |
| Liver Disease Diagnosis and Treatment | Lifetime | 115 | DE 8 | 99.80 |
| Metabolism, Diabetes, and Cancer | Lifetime | 50 | DE 2 | 99.72 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 134 | DE 9 | 99.28 |
| Diabetes Treatment and Management | Lifetime | 174 | DE 12 | 99.28 |
| Muscle metabolism and nutrition | Lifetime | 144 | DE 3 | 99.09 |
| Diabetes and associated disorders | Lifetime | 204 | DE 7 | 98.98 |
| Pancreatic function and diabetes | Lifetime | 302 | DE 19 | 99.02 |
| Diabetes Management and Research | Lifetime | 457 | DE 22 | 98.41 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 598 | DE 15 | 98.12 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 572 | DE 24 | 96.40 |
| Regulation of Appetite and Obesity | Lifetime | 676 | DE 37 | 96.35 |
| Cardiovascular Disease and Adiposity | Lifetime | 941 | DE 48 | 95.75 |
| Pharmacology and Obesity Treatment | Lifetime | 762 | DE 38 | 92.58 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 857 | DE 60 | 88.65 |
| Diet and metabolism studies | 2021-2025 | 15 | DE 2 | 99.69 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 38 | DE 4 | 99.77 |
| Adipose Tissue and Metabolism | 2021-2025 | 15 | DE 2 | 98.96 |
| Diet, Metabolism, and Disease | 2021-2025 | 11 | DE 2 | 99.71 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 18 | DE 1 | 99.35 |
| Diabetes Treatment and Management | 2021-2025 | 123 | DE 11 | 98.63 |
| Diabetes and associated disorders | 2021-2025 | 82 | DE 6 | 97.67 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 72 | DE 6 | 94.06 |
| Alcohol Consumption and Health Effects | 2021-2025 | 137 | DE 5 | 93.80 |
| Liver Disease and Transplantation | 2021-2025 | 515 | DE 23 | 95.18 |
| Diabetes Management and Research | 2021-2025 | 583 | DE 26 | 93.57 |
| Pancreatic function and diabetes | 2021-2025 | 685 | DE 39 | 89.95 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 591 | DE 15 | 88.99 |
| Pharmacology and Obesity Treatment | 2021-2025 | 178 | DE 9 | 86.63 |
| Pain Mechanisms and Treatments | 2021-2025 | 929 | DE 56 | 80.98 |
| Diabetes Management and Education | 2021-2025 | 997 | DE 28 | 72.29 |
| Apelin-related biomedical research | 2021-2025 | 707 | DE 25 | 35.15 |
